W Müller

541 total citations
21 papers, 360 citations indexed

About

W Müller is a scholar working on Rheumatology, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, W Müller has authored 21 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 4 papers in Public Health, Environmental and Occupational Health and 4 papers in Physiology. Recurrent topics in W Müller's work include Rheumatoid Arthritis Research and Therapies (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). W Müller is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). W Müller collaborates with scholars based in Switzerland, Netherlands and Germany. W Müller's co-authors include A M Boerbooms, H. J. Van Beusekom, Stefan Meuer, J. Schrezenmeir, Bernd Schweikert, J. Beyer, George J. Kahaly, U. Krause, Jan Stolk and Leo B. A. Van De Putte and has published in prestigious journals such as European Journal of Clinical Investigation, Klinische Pädiatrie and Schweizer Archiv für Tierheilkunde.

In The Last Decade

W Müller

19 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W Müller Switzerland	7	139	100	82	67	55	21	360
Rosalind Ramsey‐Goldman United States	6	103 0.7×	235 2.4×	50 0.6×	103 1.5×	8 0.1×	8	500
Alexis Harris United States	12	51 0.4×	43 0.4×	16 0.2×	42 0.6×	8 0.1×	21	385
Michael G. Cohen Australia	15	38 0.3×	230 2.3×	15 0.2×	57 0.9×	4 0.1×	26	425
Yvonne Norton United Kingdom	5	73 0.5×	309 3.1×	11 0.1×	17 0.3×	11 0.2×	8	401
Marco A. Ramírez‐Ortiz Mexico	10	48 0.3×	32 0.3×	18 0.2×	43 0.6×	149 2.7×	28	306
A. B. Parkes United Kingdom	10	60 0.4×	25 0.3×	273 3.3×	23 0.3×	3 0.1×	17	391
Rochella A. Ostrowski United States	10	50 0.4×	129 1.3×	11 0.1×	9 0.1×	77 1.4×	14	282
R. Hal Scofield United States	3	150 1.1×	196 2.0×	57 0.7×	13 0.2×	3 0.1×	5	359
Alejandro Díaz-Borjón Mexico	9	18 0.1×	88 0.9×	25 0.3×	21 0.3×	5 0.1×	16	366
Julia Ash United States	9	38 0.3×	152 1.5×	5 0.1×	92 1.4×	19 0.3×	16	317

Countries citing papers authored by W Müller

Since Specialization

Citations

This map shows the geographic impact of W Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Müller more than expected).

Fields of papers citing papers by W Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Müller. The network helps show where W Müller may publish in the future.

Co-authorship network of co-authors of W Müller

This figure shows the co-authorship network connecting the top 25 collaborators of W Müller. A scholar is included among the top collaborators of W Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Müller. W Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Müller, W, et al.. (2013). Allopurinol-Therapie bei importierten Hunden mit Leishmaniose ausserhalb des Endemiegebietes. Schweizer Archiv für Tierheilkunde. 155(10). 559–567. 7 indexed citations

2.

Keller, Christian, et al.. (2012). Epistaxis, Maculopapular Rash and Fever in a German Boy After a Stay in Thailand Caused by Orientia Tsutsugamushi. Klinische Pädiatrie. 224(4). 270–271. 5 indexed citations

3.

Waßmuth, Ralf, et al.. (2001). The presence of HLA-DR B1 shared motif does not influence cyclophosphamide and methotrexate cytotoxicity in rheumatoid arthritis patients.. PubMed. 10(4). 235–41. 1 indexed citations

4.

Stolk, Jan, A M Boerbooms, Ronney A. De Abreu, et al.. (1998). Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis. Arthritis & Rheumatism. 41(10). 1858–1866. 78 indexed citations

5.

Stolk, Jan, A M Boerbooms, Ronney A. De Abreu, et al.. (1998). Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis. Arthritis & Rheumatism. 41(10). 1858–1866. 3 indexed citations

6.

Łacki, J K, T. Schochat, Magdalena Sobieska, et al.. (1994). Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide.. PubMed. 53(2). 76–82. 19 indexed citations

7.

Laffer, U, U Metzger, P Aeberhard, et al.. (1992). [Final evaluation of the randomized multicenter study SAKK 40/81: adjuvant portal chemotherapy of curatively resected colorectal cancer].. PubMed. 58(5). 755–8. 1 indexed citations

8.

Sobieska, Magdalena, et al.. (1992). [Can thermal therapy of ankylosing spondylitis induce an activation of the disease?].. PubMed. 51(3). 127–31. 12 indexed citations

9.

Jeurissen, M. E. C., A M Boerbooms, Levinus B. A. van de Putte, et al.. (1991). Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty‐eight–week randomized, double‐blind trial. Arthritis & Rheumatism. 34(8). 961–972. 78 indexed citations

10.

Aeschlimann, André, et al.. (1991). [Alpha-1-acid glycoprotein in differential diagnosis of rheumatic diseases].. PubMed. 86(10). 491–7. 1 indexed citations

11.

Metzger, U, U Laffer, R Egeli, et al.. (1989). [Initial results of adjuvant portal liver infusion following radical surgery of colorectal cancer (Swiss Study Group for Epidemiologic and Clinical Cancer Research Study 40/81)].. PubMed. 56(4). 455–60. 2 indexed citations

12.

Laffer, U, F Harder, U Metzger, et al.. (1989). [Blood transfusions and prognosis following curative resection of colorectal cancer: is there an association?].. PubMed. 56(4). 461–4. 2 indexed citations

13.

Aeschlimann, André, D. Brackertz, H Kaiser, & W Müller. (1988). [Chlorambucil pulse therapy in progressive chronic polyarthritis. Initial results of an open multicenter study].. PubMed. 46(5). 241–4. 1 indexed citations

14.

Kahaly, George J., J. Schrezenmeir, U. Krause, et al.. (1986). Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study. European Journal of Clinical Investigation. 16(5). 415–422. 125 indexed citations

15.

Müller, W, et al.. (1985). [Somatostatin in active psoriatic arthritis].. PubMed. 43(6). 291–3. 3 indexed citations

16.

Müller, W, et al.. (1982). Oral gold therapy with auranofin (SK&F 39162). A multicenter open study in patients with rheumatoid arthritis.. PubMed. 8. 154–9. 12 indexed citations

17.

Hell, Daniel, et al.. (1982). [Generalized fibrositis syndrome and personality: a controlled study (author's transl)].. PubMed. 71(24). 1014–21. 1 indexed citations

18.

Müller, W, et al.. (1963). [On the diagnosis of the activity of chronic rheumatic diseases, with special reference to the quantitative determination of haptoglobins and caeruloplasmin].. PubMed. 22. 1–10. 2 indexed citations

19.

Müller, W & Eugene W. Schupp. (1959). [Comparison of the Waaler-Rose hemagglutination reaction & the latex fixation test in rheumatic disorders].. PubMed. 18(3-4). 97–113. 2 indexed citations

20.

Müller, W. (1956). [The value of C-reactive protein in determining the degree of activity of acute rheumatic diseases].. PubMed. 15(1-2). 31–47. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact